We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Novartis to Pursue Product Divestiture to Gain EU Approval of Hexal Merger
Novartis to Pursue Product Divestiture to Gain EU Approval of Hexal Merger
May 10, 2005
Novartis is proposing to divest a small group of pharmaceutical products as a means to gain European Union (EU) approval for its acquisition of German generics company Hexal AG.